- Home
- NXGL vs HOOK Comparison
NXGL vs HOOK Comparison
Compare NXGL & HOOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXGL
- HOOK
- Stock Information
- Founded
- NXGL 1997
- HOOK 2011
- Country
- NXGL United States
- HOOK United States
- Employees
- NXGL N/A
- HOOK N/A
- Industry
- NXGL Medical/Dental Instruments
- HOOK Biotechnology: Pharmaceutical Preparations
- Sector
- NXGL Health Care
- HOOK Health Care
- Exchange
- NXGL Nasdaq
- HOOK Nasdaq
- Market Cap
- NXGL 23.8M
- HOOK 24.5M
- IPO Year
- NXGL 2021
- HOOK 2019
- Fundamental
- Price
- NXGL $3.28
- HOOK $1.99
- Analyst Decision
- NXGL
- HOOK Buy
- Analyst Count
- NXGL 0
- HOOK 4
- Target Price
- NXGL N/A
- HOOK $10.67
- AVG Volume (30 Days)
- NXGL 121.9K
- HOOK 266.1K
- Earning Date
- NXGL 11-13-2024
- HOOK 03-21-2025
- Dividend Yield
- NXGL N/A
- HOOK N/A
- EPS Growth
- NXGL N/A
- HOOK N/A
- EPS
- NXGL N/A
- HOOK N/A
- Revenue
- NXGL $6,729,000.00
- HOOK $49,999,000.00
- Revenue This Year
- NXGL $120.47
- HOOK $148.80
- Revenue Next Year
- NXGL $38.19
- HOOK N/A
- P/E Ratio
- NXGL N/A
- HOOK N/A
- Revenue Growth
- NXGL 90.57
- HOOK 143.30
- 52 Week Low
- NXGL $1.84
- HOOK $1.72
- 52 Week High
- NXGL $5.10
- HOOK $10.50
- Technical
- Relative Strength Index (RSI)
- NXGL 38.55
- HOOK 45.83
- Support Level
- NXGL $3.27
- HOOK $1.80
- Resistance Level
- NXGL $3.93
- HOOK $1.99
- Average True Range (ATR)
- NXGL 0.38
- HOOK 0.24
- MACD
- NXGL -0.09
- HOOK 0.05
- Stochastic Oscillator
- NXGL 11.02
- HOOK 25.35
About NXGL NexGel Inc
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating, and cross-linking technologies.
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.